Abstract: The present invention provides methods and systems for performing quality control metrics in hybridization assays. In particular, the present invention provides for quality control metrics for nucleic acid enrichment on hybridization assay formats, such as microarray assays.
Type:
Application
Filed:
February 2, 2009
Publication date:
August 13, 2009
Applicant:
ROCHE NIMBLEGEN, INC.
Inventors:
CHRISTINA MIDDLE, JACOB KITZMAN, TODD RICHMOND, THOMAS ALBERT, JEFFREY JEDDELOH
Abstract: The present invention provides methods and systems for the capture and enrichment of target nucleic acids and analysis of the enriched target nucleic acids. In particular, the present invention provides for the enrichment of targeted sequences in a solution based format.
Abstract: The present invention is a microarray having a plurality of subarrays with a hydrophobic barrier that defines each subarray of the microarray, and a method for preparing such a microarray. The hydrophobic barrier is prepared using a microarray synthesis instrument, where NPPOC photoprotected and other hydrophobic group-bearing phosphoramidites are coupled to the microarray using light from a digital micromirror to direct formation of the hydrophobic barrier. The method utilizes hydrophobicity, a well-established property, of conventional phosphoramidite protecting groups for an entirely new application, the synthesis of hydrophobic barriers on microarrays.
Type:
Grant
Filed:
September 29, 2003
Date of Patent:
March 3, 2009
Assignee:
Roche Nimblegen, Inc.
Inventors:
Mark McCormick, Klaus-Peter Stengele, Gary Barrett, Roland Green
Abstract: The present inventions provides an apparatus and method for the parallel loading of multiple samples in a microarray containing a plurality of sub-arrays. The method makes use of a microarray containing multiple sub-arrays, a loading channel array, and a fluid handling robot or an assembly robot or machine.
Type:
Grant
Filed:
September 30, 2003
Date of Patent:
January 27, 2009
Assignee:
Roche Nimblegen, Inc.
Inventors:
Roland D. Green, Mark McCormick, Gary Barrett
Abstract: The present invention relates to novel nucleoside derivatives of general formula (I) wherein R1=H, halogen, NO2, CN, OCH3, an alkyl, alkoxy or alkoxyalkyl residue having 1 to 4 C atoms, preferably a methyl, ethyl, propyl or butyl residue or an optionally substituted aryl residue or aliphatic acyl residue having 2 to 5 atoms, R2 to R7=H, NO2, CN, OCH3, a branched or unbranched alkyl, alkoxy or alkoxyalkyl residue having 1 to 5 C atoms or an optionally substituted aryl residue or an aliphatic acyl residue having 2 to 5 atoms, X is the group C?O or C?S, Y?S, O, NR?, C(R?)2, wherein R? is H, or a branched or unbranched alkyl residue having 1 to 5 C atoms or an optionally substituted aryl residue, Z=SO2, OCO, OCS, SCS, and N is a nucleotide.